nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—OPRM1—nicotine dependence	0.939	1	CbGaD
Ketobemidone—Pethidine—OPRM1—nicotine dependence	0.00467	1	CrCbGaD
Ketobemidone—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00338	0.0599	CbGpPWpGaD
Ketobemidone—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00286	0.0507	CbGpPWpGaD
Ketobemidone—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.00264	0.0468	CbGpPWpGaD
Ketobemidone—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00256	0.0453	CbGpPWpGaD
Ketobemidone—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00233	0.0413	CbGpPWpGaD
Ketobemidone—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.0021	0.0371	CbGpPWpGaD
Ketobemidone—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00178	0.0314	CbGpPWpGaD
Ketobemidone—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00158	0.0281	CbGpPWpGaD
Ketobemidone—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00145	0.0256	CbGpPWpGaD
Ketobemidone—OPRD1—Peptide GPCRs—OPRM1—nicotine dependence	0.00102	0.0181	CbGpPWpGaD
Ketobemidone—OPRD1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000962	0.017	CbGpPWpGaD
Ketobemidone—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.000953	0.0169	CbGpPWpGaD
Ketobemidone—PTGS1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000925	0.0164	CbGpPWpGaD
Ketobemidone—OPRK1—Peptide GPCRs—OPRM1—nicotine dependence	0.000896	0.0159	CbGpPWpGaD
Ketobemidone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000871	0.0154	CbGpPWpGaD
Ketobemidone—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00086	0.0152	CbGpPWpGaD
Ketobemidone—OPRK1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000843	0.0149	CbGpPWpGaD
Ketobemidone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000737	0.0131	CbGpPWpGaD
Ketobemidone—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000728	0.0129	CbGpPWpGaD
Ketobemidone—OPRM1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000713	0.0126	CbGpPWpGaD
Ketobemidone—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000706	0.0125	CbGpPWpGaD
Ketobemidone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000658	0.0117	CbGpPWpGaD
Ketobemidone—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00065	0.0115	CbGpPWpGaD
Ketobemidone—UGT1A9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00064	0.0113	CbGpPWpGaD
Ketobemidone—UGT1A9—Biological oxidations—CYP2A7—nicotine dependence	0.000603	0.0107	CbGpPWpGaD
Ketobemidone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0006	0.0106	CbGpPWpGaD
Ketobemidone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000598	0.0106	CbGpPWpGaD
Ketobemidone—UGT1A9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000595	0.0105	CbGpPWpGaD
Ketobemidone—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000592	0.0105	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000582	0.0103	CbGpPWpGaD
Ketobemidone—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000534	0.00945	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000511	0.00904	CbGpPWpGaD
Ketobemidone—PTGS1—Biological oxidations—CYP2A7—nicotine dependence	0.000492	0.0087	CbGpPWpGaD
Ketobemidone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000486	0.00861	CbGpPWpGaD
Ketobemidone—OPRD1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000481	0.00851	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000432	0.00764	CbGpPWpGaD
Ketobemidone—OPRK1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000421	0.00746	CbGpPWpGaD
Ketobemidone—OPRD1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000406	0.00718	CbGpPWpGaD
Ketobemidone—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000398	0.00705	CbGpPWpGaD
Ketobemidone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000396	0.00701	CbGpPWpGaD
Ketobemidone—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000391	0.00692	CbGpPWpGaD
Ketobemidone—OPRD1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000376	0.00666	CbGpPWpGaD
Ketobemidone—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.000375	0.00664	CbGpPWpGaD
Ketobemidone—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00037	0.00655	CbGpPWpGaD
Ketobemidone—OPRK1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000356	0.0063	CbGpPWpGaD
Ketobemidone—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000337	0.00596	CbGpPWpGaD
Ketobemidone—OPRK1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00033	0.00584	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000329	0.00583	CbGpPWpGaD
Ketobemidone—OPRD1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000322	0.00571	CbGpPWpGaD
Ketobemidone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000321	0.00568	CbGpPWpGaD
Ketobemidone—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.000318	0.00562	CbGpPWpGaD
Ketobemidone—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000313	0.00555	CbGpPWpGaD
Ketobemidone—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000301	0.00532	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000299	0.00529	CbGpPWpGaD
Ketobemidone—OPRD1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000293	0.00519	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000289	0.00511	CbGpPWpGaD
Ketobemidone—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000283	0.00502	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000283	0.00501	CbGpPWpGaD
Ketobemidone—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00028	0.00495	CbGpPWpGaD
Ketobemidone—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000274	0.00485	CbGpPWpGaD
Ketobemidone—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000272	0.00482	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000262	0.00464	CbGpPWpGaD
Ketobemidone—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000258	0.00458	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.000258	0.00457	CbGpPWpGaD
Ketobemidone—OPRK1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000257	0.00455	CbGpPWpGaD
Ketobemidone—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000255	0.00451	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.000246	0.00435	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000244	0.00432	CbGpPWpGaD
Ketobemidone—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000239	0.00422	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—FGD1—nicotine dependence	0.000235	0.00415	CbGpPWpGaD
Ketobemidone—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000233	0.00413	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—FGD1—nicotine dependence	0.000226	0.00401	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000222	0.00392	CbGpPWpGaD
Ketobemidone—OPRM1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000217	0.00385	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—OPRM1—nicotine dependence	0.000215	0.00381	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—FGD1—nicotine dependence	0.000206	0.00364	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000204	0.00362	CbGpPWpGaD
Ketobemidone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000202	0.00357	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000191	0.00339	CbGpPWpGaD
Ketobemidone—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000181	0.0032	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000178	0.00314	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000177	0.00313	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000174	0.00308	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000173	0.00306	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00017	0.00302	CbGpPWpGaD
Ketobemidone—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000168	0.00298	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—DRD2—nicotine dependence	0.000156	0.00276	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TAS2R16—nicotine dependence	0.000155	0.00274	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000139	0.00246	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—FGD1—nicotine dependence	0.000139	0.00245	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—DRD2—nicotine dependence	0.000132	0.00233	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000131	0.00232	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—OPRM1—nicotine dependence	0.000126	0.00223	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—AKR1B10—nicotine dependence	0.000122	0.00217	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000122	0.00215	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—FGD1—nicotine dependence	0.000121	0.00215	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—OPRM1—nicotine dependence	0.00011	0.00196	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AKR1B10—nicotine dependence	0.000107	0.0019	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CYP2A7—nicotine dependence	0.000103	0.00183	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—FGD1—nicotine dependence	0.000103	0.00182	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—DRD2—nicotine dependence	0.0001	0.00178	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—DRD2—nicotine dependence	9.11e-05	0.00161	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AKR1B10—nicotine dependence	9.07e-05	0.00161	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—DRD2—nicotine dependence	8.8e-05	0.00156	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—WASF2—nicotine dependence	8.62e-05	0.00153	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP2A7—nicotine dependence	8.41e-05	0.00149	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—WASF1—nicotine dependence	8.27e-05	0.00146	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—DRD2—nicotine dependence	7.99e-05	0.00141	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—WASF2—nicotine dependence	7.56e-05	0.00134	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—OPRM1—nicotine dependence	7.44e-05	0.00132	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—DRD2—nicotine dependence	7.43e-05	0.00132	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—WASF1—nicotine dependence	7.25e-05	0.00128	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—DRD2—nicotine dependence	6.75e-05	0.0012	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—OPRM1—nicotine dependence	6.53e-05	0.00116	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP2A7—nicotine dependence	6.41e-05	0.00114	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—WASF2—nicotine dependence	6.39e-05	0.00113	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—WASF1—nicotine dependence	6.13e-05	0.00108	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP2A7—nicotine dependence	5.43e-05	0.000962	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—DRD2—nicotine dependence	5.38e-05	0.000953	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP2A7—nicotine dependence	4.85e-05	0.000858	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—DRD2—nicotine dependence	4.72e-05	0.000836	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP2A7—nicotine dependence	4.42e-05	0.000783	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—DRD2—nicotine dependence	3.99e-05	0.000706	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2.91e-05	0.000516	CbGpPWpGaD
